Gsk (GSK) Shares Outstanding (2017 - 2025)

Gsk's Shares Outstanding history runs 9 years deep, the most recent figure standing at $5.7 billion for Q4 2025.

• In Q4 2025, Shares Outstanding rose 3.66% year-over-year to $5.7 billion; the TTM figure through Dec 2025 stood at $5.7 billion (up 3.66% YoY), while the FY2025 annual figure was $5.7 billion, up 3.17% from the prior year.
• Shares Outstanding was $5.7 billion for Q4 2025 at Gsk, up from $5.5 billion in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $7.3 billion in Q4 2021 to a low of $5.1 billion in Q4 2022.
• Historically, Shares Outstanding has averaged $5.8 billion across 5 years, with a median of $5.5 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding plunged 30.36% in 2022, then grew 5.84% in 2023.
• A 5-year view of Shares Outstanding shows it stood at $7.3 billion in 2021, then sank by 30.36% to $5.1 billion in 2022, then gained by 5.84% to $5.4 billion in 2023, then rose by 3.46% to $5.5 billion in 2024, then increased by 3.66% to $5.7 billion in 2025.
• The last three Shares Outstanding figures came in at $5.7 billion (Q4 2025), $5.5 billion (Q4 2024), and $5.4 billion (Q4 2023), per Business Quant data.